Moderna Inc
NASDAQ:MRNA 4:00:00 PM EDT
Products
Health Canada Says Is Aware U.S. FDA Has Issued Emergency Use Authorization For Moderna Covid-19 Vaccine
Published: 12/19/2020 03:09 GMT
Moderna Inc (MRNA) - Statement on the U.S. Authorization of the Moderna Covid-19 Vaccine.
Health Canada Says is Aware U.S. Food and Drug Administration Has Issued Emergency Use Authorization for a Covid-19 Vaccine Manufactured by Moderna.
Health Canada Says Has Been Reviewing Moderna's Vaccine Since It Was Submitted on October 12, 2020, and is Expediting Review of Covid-19 Vaccines.
Health Canada Says There is Still Information, Data to Be Provided by Moderna for Review.
Health Canada Says Cannot Provide a Definite Timeline for Completion of Vaccine Review at This Time.
Health Canada Says Review is Expected to Be Completed in Coming Weeks.
Health Canada Says is Working Closely With International Regulators, Including U.S. FDA, to Share Information, Data on Vaccines Under Review.
Health Canada Says Review is Being Done Through Rolling Submissions, Where Data is Being Reviewed As It Becomes Available From Manufacturer.
Health Canada Says is Aware U.S. Food and Drug Administration Has Issued Emergency Use Authorization for a Covid-19 Vaccine Manufactured by Moderna.
Health Canada Says Has Been Reviewing Moderna's Vaccine Since It Was Submitted on October 12, 2020, and is Expediting Review of Covid-19 Vaccines.
Health Canada Says There is Still Information, Data to Be Provided by Moderna for Review.
Health Canada Says Cannot Provide a Definite Timeline for Completion of Vaccine Review at This Time.
Health Canada Says Review is Expected to Be Completed in Coming Weeks.
Health Canada Says is Working Closely With International Regulators, Including U.S. FDA, to Share Information, Data on Vaccines Under Review.
Health Canada Says Review is Being Done Through Rolling Submissions, Where Data is Being Reviewed As It Becomes Available From Manufacturer.